LP15253-5
Ceftizoxime
Active
Description
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Ceftizoxime
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Ceftizoxime
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP15253-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP15253-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 头孢唑肟 Synonyms: 去甲噻肟头孢菌素; |
| fr-CA | French (Canada) | Ceftizoxime |
| et-EE | Estonian (Estonia) | Tseftisoksiim |
| es-ES | Spanish (Spain) | Ceftizoxima |
| it-IT | Italian (Italy) | Ceftizoxime |
| tr-TR | Turkish (Turkey) | Seftizoksim |
| ru-RU | Russian (Russian Federation) | Цефтизоксим |
| nl-NL | Dutch (Netherlands) | ceftizoxime |
| fr-BE | French (Belgium) | Ceftizoxime |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright